Blue Water Biotech, Inc. announced that effective as of August 16, 2023, Joseph Hernandez resigned as Chief Executive Officer. Effective August 16, 2023, Board has appointed Jon Garfield, the Company?s Chief Financial Officer, to serve as the Company?s interim principal executive officer during the pendency of Mr. Sapirstein?s appointment. During this period, Mr. Garfield shall have general supervision and direction of the business and affairs of the Company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2063 USD | -13.28% | +13.41% | +4.19% |
05-20 | Onconetix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-11 | Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+4.19% | 4.23M | |
-1.62% | 90.85B | |
-0.92% | 39.02B | |
-9.57% | 33.46B | |
-17.98% | 14.51B | |
-6.74% | 13.22B | |
-9.76% | 11.65B | |
-47.31% | 10.57B | |
+6.52% | 9.23B | |
+137.06% | 7.71B |
- Stock Market
- Equities
- ONCO Stock
- News Onconetix, Inc.
- Blue Water Biotech, Inc. Announces CEO Changes